glp-1 agonist history Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies It's important to study the
Description
Bottom line When comparing Wegovy vs
van Bloemendaal, L., Ten Kulve, J
We filed for FDA approval of Wegovy pill in February 2025, and our submission was accepted in May 2025
Subsequently, adding a GLP1-RA can enhance cardiovascular protection and further renal benefits, particularly in patients with high cardiovascular risk or significant albuminuria
10.1016/j.arth.2023.12.023 [DOI] [PubMed] [Google Scholar] 61.Hulst AH, Plummer MP, Hollmann MW, DeVries JH, Preckel B, Deane AM et al (2018) Systematic review of incretin therapy during peri-operative and intensive care
